Skip to main content

Advertisement

Table 2 Concentrations of immune parameters and monocyte markers in TS and healthy controls

From: Altered monocyte activation markers in Tourette’s syndrome: a case–control study

Variable Group Mean ± SD Rank sum z-value p-value*
Monocytes/nl Patients 0.57 ± 0.22 50.1 −2.152 0.031
  Controls 0.47 ± 0.11 38.37   
TNF-alpha pg/ml Patients 0.43 ± 0.18 33.09 −2.421 0.015
  Controls 0.56 ± 0.25 45.39   
IL-6 pg/ml Patients 1.89 ± 1.71 39.41 −1.215 n.s.
  Controls 1,74 ± 1,64 33.43   
IL1-ra ng/ml Patients 0.03 ± 0.09 36.11 −2.813 0.005
  Controls 0.04 ± 0.06 51.24   
sCD14 ng/ml Patients 6.37 ± 1.43 30.25 −4.934 <0.0001
  Controls 8.40 ± 2.00 56,68   
CRP mg/dl Patients 0.43 ± 0.27 45.53 −2.013 0.044
  Controls 0.37 ± 0.37 37.85   
Neopterin nmol/l Patients 6.03 ± 2.19 48.51 −2.084 0.037
  Controls 5.19 ± 1.84 37.36   
  1. SD = standard deviation, n.s. = not significant; *Mann–Whitney U Test.